Biophysics Seminar

GC4419 is a normal tissue radioprotector that also enhances the anti-tumor effects of high dose per fraction radiation and immune therapy

Name: GC4419 is a normal tissue radioprotector that also enhances the anti-tumor effects of high dose per fraction radiation and immune therapy
Start: 2019-03-05T11:30:00+01:00
End: 2019-03-05T12:30:00+01:00
Location: GSI Helmholtzzentrum für Schwerionenforschung GmbH

durch Dr. Anthony J. Davis (Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA), Dr. Michael Dean Story (Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA)

Dienstag 05.03.2019, 11:30 → 12:30 Europe/Berlin

Lecture hall, Theory SB3 3.170a (GSI Helmholtzzentrum für Schwerionenforschung GmbH)

Lecture hall, Theory SB3 3.170a

GSI Helmholtzzentrum für Schwerionenforschung GmbH

Planckstraße 1, 64291 Darmstadt, Germany

Wähle Zeitzone

GC4419 is a normal tissue radioprotector that also enhances the anti-tumor effects of high dose per fraction radiation and immune therapy

durch Dr. Anthony J. Davis (Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA), Dr. Michael Dean Story (Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA)

Lecture hall, Theory SB3 3.170a

GSI Helmholtzzentrum für Schwerionenforschung GmbH